Effective intracellular expression of small RNA therapeutics inclusion of specific U6 snRNA sequences from positions depends on a number of factors. The RNA, whether anti-+19 to +27. In situ localization of the transcripts shows that sense, ribozyme, or RNA aptamer, must be efficiently tranboth tRNA and U6 promoter transcripts give primarily puncscribed, stabilized against rapid degradation, folded cortate nuclear patterns, and that capping of transcripts is not rectly, and directed to the part of the cell where it can be required for nuclear retention. Several different insert most effective. To overcome a number of these problems RNAs directed against HIV-1 were tested by cotransfection we have been testing expression cassettes based on the with HIV-1 provirus and assay for subsequent viral reverse human tRNA met and U6 snRNA promoters, in which trantranscriptase production. These include antisense RNA, scripts encoding small RNA inserts are protected against hairpin and hammerhead ribozymes, and RNA ligands attack from the 3′ end. Transient expression in cultured (aptamers) for Tat and Rev RNA binding proteins. Results cells results in 10 3 -2 × 10 7 full-length transcripts per cell, show that Rev-binding RNAs efficiently block HIV-1 gene depending partially on the promoter construct used but expression, whereas other RNAs have little or no effect also on the nature of the insert RNA. 5′ ␥-Phosphate when expressed in these cassettes. methylation (capping) depended, as expected, on the
Introduction nucleolus, and cytoplasm have been identified. A number of different strategies have been envisioned U6 is a small, stable RNA that exists as an abundant for inhibiting viral infections and uncontrolled cell nuclear ribonucleoprotein (U6 snRNP) in all human cells, growth by delivering therapeutic nucleic acids to affected where it plays central roles in both spliceosome assembly cells. In approaches where the cells are induced to synand catalysis in nuclear pre-mRNA splicing. All of the thesize their own protective nucleic acids from exogenmajor transcriptional promoter elements for RNA polyously supplied genes, the choice of nucleic acid is RNA merase III (pol III) are upstream of the transcription because the cell can produce intracellular single stranded start. [13] [14] [15] [16] This upstream U6 promoter strategy confers a RNA in quantity. Several types of RNA inhibitors are potential advantage over the use of other pol III protheoretically possible, including antisense RNA, catalytic moters (5S rRNA and tRNA classes), where insert RNA RNA (ribozymes), and high-affinity RNA ligands, termed must be expressed as a fusion with the RNA sequences 'aptamers' or 'decoys'. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] encoding the intragenic promoters. This is of special conTo deliver successfully the RNA inhibitors to their cern in strategies using viral RNAs, which might have intended targets in the appropriate subcellular compartcytotoxic effects, for example Refs 17 and 18) . A number ments it is necessary first to identify promoter strategies of such tRNA gene fusions have been tested both in and RNA signals that specify the desired localization. A experimental organisms and as potential expression casspecific and promising example of this has been provided settes for small RNAs in gene therapy. 10, 11, [19] [20] [21] An by embedding a ribozyme in a pseudoviral transcript that additional advantage of the U6 gene is that individual might be copackaged with the bona fide retroviral trangenes are heavily expressed in human cells. Transcription scripts, thus providing directed access to the target of only a few copies of the U6 gene (out of 200 or more sequence. 12 Many types of inhibitors are likely to require pseudogenes 22 ) results in roughly 400 000 copies of RNA either nuclear or less constrained cytoplasmic delivery, per cell. 23 The U6 primary transcript is normally trapped however. In principle this should be possible for many in the nucleus, appearing both in the nucleoplasm and in localized nuclear 'speckles'. 24 This is in contrast to other small nuclear RNAs synthesized by pol II, which exit to 46 In this report the human U6 promoter and different those used previously). 10, 11 All of the transcripts tested here have strong, artificial stems with stable tetraloops amounts of U6 RNA coding sequence have been used to drive the expression of small ribozymes, antisense oligoafter the insert sites and immediately preceding the polyU terminator for pol III. This structure is expected to ribonucleotides, and RNA aptamers directed against HIV-1 RNA and proteins. The amount, degree of proprotect against 3′-5′ exonuclease attack, the most prevalent small RNA breakdown pathway, and to reduce the cessing, and location of the RNA expressed in human cells is examined, as is the degree to which expression of chances of the 3′ trailer interfering with the insert RNA folding. The restriction cloning sites between the inserts these RNAs inhibits HIV-1 gene expression. and the flanking sequences (5′ leaders and 3′ stems) serve as structural spacers.
Results
The tRNA transcript contains only the leading three quarters of the native tRNA sequence. It was expected Promoter cassettes and inserts that this structural perturbation would prevent pre-tRNA Figure 1a shows a schematic representation of the U6 5′ and 3′ end processing, thus keeping the 5′ end of the gene cassette that was used for expression of small RNA insert protected and preventing export from the nucleus. inserts, with the expected secondary structure of the tranThe U6 expression cassettes were of three types. All had scripts below. Figure 1b shows terminator. The only difference was that the three types of endogenous U6 snRNA per cell. 23 We also tested RNA from a limited number of constructs for the presence of of transcripts began with different amounts of U6 RNA. 'U6+1' began with +1 as the SalI cloning site for the insert, a 5′ ␥-phosphomethyl cap by Northern analysis after immunoprecipitation with antibodies directed against thus having no U6 RNA and only a short leader corresponding to the SalI sequence. 'U6+19' had the SalI site this cap. 27 The results are summarized in the right hand column in Table 1 . The signal, after normalization for the inserted after +19, which includes the leading stem of U6. 'U6+27' had the SalI site after +27. This construct, shown efficiency of endogenous U6 snRNA precipitation, showed essentially the expected results for capping. The in Figure 1a , also includes the full sequence required for 5′ ␥-phosphomethyl 'capping' and stabilization. 16, [27] [28] [29] U6+27 transcripts capped with reasonable efficiency, while the U6+1 RNAs and tRNA fusions were uncapped The +19 to +27 sequence was implicated in stability, as well as capping, and the capping was hypothesized to and the U6+19 capped poorly (8%). The levels of RNA from different promoters with the signal nuclear retention. It was possible on the basis of the existing data, however, that only the +1 to +19 stem same insert were essentially what was expected. tRNAfused RNA levels were high, as were the U6+27 tranwas required for stability and that this RNA would find its way to the cytoplasm without the 5′-␥-phosphomethyl scripts that were predicted to be most stable because of the cap. The U6+19 and U6+1 transcripts had progresscap. In practice, steady-state levels of RNA increased from U6+1 to U6+19 to U6+27, but the localization ively lower levels within each insert group. The levels of RNA in response to the insert type changed even more remained similar (see below).
Six general types of inserts were cloned into these casdramatically, however, and in ways that were not predictable in advance. The antisense inserts, which we settes and tested for the levels of RNA expression and their degree of processing. Four of the inserts are shown would have predicted to be the most open to endonucleolytic attack because they lack strong structure, instead in Figure 2 . Two of these are ribozymes, either the hammerhead or hairpin directed against the same site in the accumulated to the highest level of any tested insert. The hairpin ribozyme, TAR structure, and RBE were main-U5 region successfully targeted previously. 30, 31 For the hammerhead, two lengths of annealing domain were tained at slightly lower but still high levels. In contrast, the hammerhead ribozyme levels were 15-to 20-fold used (HH1 versus HH2) to test either aggressive annealing or better product release to encourage turnlower than the levels of hairpin in the same promoter backbones. over. In addition, a simple antisense clone was produced corresponding to the same 28 nt annealing sequence as the longer hammerhead, but without a catalytic domain.
Destinations of expressed RNAs
In situ hybridization methods were used to locate tranTwo types of aptamers were initially tested. One is minimal HIV-1 TAR (in the 5′ leader LTR transcript) that is scripts with probes specific to the inserts. Digoxigeninlabeled DNA probes for U6 snRNA or the insert plus terrequired for Tat binding, and the other is an aptamer corresponding to the small Rev-binding element (RBE) subminator stem were annealed to the RNA in fixed cells, and detected by confocal fluorescent microscopy using domain of the RRE (at the end of the env gene). 32 Additional aptamers of varying sequences that were pre-FITC antibodies against the digoxigenin-11-dUMP tag. Figure 4a shows a control experiment in which this type viously selected for high affinity to Rev were also tested for effects on HIV-1 expression (see below, 'Effectiveness of probe was directed toward endogenous U6 snRNA (left panel) and compared to staining for total cellular in preventing HIV-1 proviral gene expression').
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RNA and DNA with propidium iodide (right panel, DNA stains more brightly than RNA). Splicing compoExpression of RNA inserts Figure 3 shows Northern blot analysis of the steady state nents like U6 snRNPs are expected to be almost exclusively nuclear, although there is disagreement as to accumulation of RNA from the different promoter/insert strategies, 2 days after transfection into human 293 cells.
whether the U6 localizes to a large or small number of punctate loci outside of the dark nucleoli (two to four For each construct, the lanes were probed with a labeled DNA oligonucleotide complementary to only the unique dark spots inside the large nuclei in each panel are nucleoli). In contrast to the one other report of U6 localiz-RNA insert. The only significant accumulation seen in cells from any of our constructs is the nearly full-length ation, 24 we find the U6 in a large number of punctate nuclear loci reminiscent of other splicing component disform, suggesting that if any processing occurs to remove the 5′ leaders or 3′ stem, the rest of the transcript does tribution observed by these fixation methods. 34 It is interesting to note that in the two cells undergoing chromonot survive long. The sizes of the RNAs are consistent with a series of RNAs that are 1-10 nucleotides shorter some condensation and division (lower left and upper right corners of panel), the U6 signal becomes dispersed than the expected primary transcripts, which terminate at the fourth U in the terminator stem ( Figure 1 ). This (non-punctate) throughout the cell. This suggests that when the nuclear envelope breaks down during division, would be consistent with slow exonuclease attack on the 3′ terminator stem.
the U6 may lose precise localization and have to be reorganized as the nucleus is reformed. Quantitative assessment of the level of RNA produced per cell in the transient transfections was obtained using Insert RNA signal from both tRNA fusions and the U6 promoters localize primarily to the nuclei in the frames Phosporimager counting of the major bands with normalization to both the percentage transfection efficiency shown in Figure 4b . Not all cells stain for the insert RNA and some cells stain more brightly than others, unlike the (usually about 70%, estimated by cotransfections with the ␤-galactosidase gene) and the endogenous level of U6 case for endogenous U6. We attribute the uneven signal to unequal transfection efficiency among cells. The sigsnRNA on the same blot (shown in the lower panel). The approximate steady state levels of RNAs from the various nals for the hairpin ribozyme insert from U6+1, U6+19, U6+27, and tRNA promoters are shown for comparison, constructs is shown in Table 1 , assuming 400 000 copies with exposure times held constant (Figure 5b ). The signal U6+27 promoters. It is possible that this increasingly diffuse staining reflects saturation of whatever was causfrom even the most poorly expressed cassette, U6+1, is easily detected. The signal from different inserts (TAR ing the RNA to locate to the nuclear 'speckles'. The nuclear localization of all of these transcripts, but and RBE) in the U6+27 cassette was very similar to that of the hairpin. It was expected that the unprocessed parespecially the U6+1 transcript, suggests that nuclear retention might be the default pathway for transcripts tial tRNA fusion transcripts would remain nuclear, since previous work in yeast and Xenopus has demonstrated that are not specifically directed to the nucleolus or cytoplasm. that transport out of the nucleus is linked to terminal processing and tRNA splicing. For the U6 transcripts, it is clear that they are primarily nuclear even without the U6
Effectiveness in preventing HIV-1 proviral gene expression capping signal, or any U6 sequences at all (+1 construct). As the level of the signal increases, the pattern is one Each of the expression constructs was tested for the ability to inhibit HIV-1 gene expression. Cotransfection of underlying punctate staining with increasingly bright nucleoplasm. In U6+1hp, the signal is primarily punctate, of the plasmids with pNL4-3 provirus (40:1 ratio) was followed by assay for viral reverse transcriptase (RTase) whereas in U6+19 at the same visual settings there is bright, diffuse nucleoplasmic staining overlaying the after 1-5 days. In repeated experiments, day 3 was found optimum in terms of RTase levels and % inhibition and punctate pattern. There is even some cytoplasmic staining in the brightest cells transfected with tRNA and the data shown in Figure 3 are for that interval. The results were averaged for triplicate assays in two to four but less well when expressed from the tRNA cassette.
From these results we concluded that high-affinity Revindependent experiments and are shown in Figure 5 . RTase activity is expressed as a percentage of the noninbinding elements in general inhibit RTase expression from the cotransfection, and that the U6 promoter strathibited proviral transfection control.
In general these antisense and ribozyme constructs in egy was working better than the tRNA promoter. these particular vectors are not very effective inhibitors (Figure 5a ). The HH2 hammerheads with long annealing Discussion domains (expressed at the lowest level) are the best of the ribozyme inhibitors, although this is only 50-60% RTase
There are a number of issues to be considered in developing optimal promoter strategies for delivering reduction, not much greater than the inhibition attained with higher levels of the antisense to the same region.
small, structured RNAs. Aside from containing signals that specify a preferred destination, the RNAs should be Similarly, the minimal TAR sequence from HIV-1 was not inhibitory in these vectors. It was only when we driven to fold in a fashion that both promotes stability and allows inserted RNA folding, independent of the surinserted an optimized Rev-binding aptamer ('U6+27RBE' in Figure 5a ) 32 that good inhibition was consistently rounding RNA. Ideally, the therapeutic RNA and any surrounding sequences should not bind cellular factors obtained. This was shown to be the result of the insert RNA's Rev-binding ability, since several different Revthat are not absolutely essential for function. In such cases high-level expression of the RNA might result in binding ligands (Figure 5b) , 32 ,33,35 gave significant inhibition of RTase activity relative to the hammerhead competition for essential proteins and toxicity. At the moment a limited amount is known about RNA signal ribozyme insert (U6+27HH control). The four new aptamer sequences all work approximately as well as the sequences that determine destinations, but several factors suggest that RNA polymerase III transcription units original RBE aptamer ('U6+27RBE') when expressed from either the U6+19 or U6+27 cassette (U6+1 was not tried), might be ideal for synthesis and delivery of small RNA 32 and the TAR sequence are also shown. Nuclear speckled patterns or staining occurred in all cases, although in cells with particularly heavy staining there appeared also to be diffuse nucleoplasmic and some cytoplasmic staining.
(a) Human 293 cells were probed with digoxigenin-labeled DNA complementary to endogenous U6 snRNA and detected with FITC-conjugated anti-digoxigenin antibodies (left panel) or stained for nucleic acids with propidium iodide. Nuclei and condensed chromosomes stain more intensely with propidium iodide. U6 signal is almost entirely in nuclear speckles in nondividing cells, with dark unstained regions corresponding to nucleoli. In cells with condensed chromosomes, U6 staining is uniformly dispersed throughout the cells, presumably due to nuclear breakdown and loss of normal localization structures. (b) 293 Cells transfected with several different expression cassette-insert combinations were probed for location of the RNA transcripts by the same digoxygenin-DNA-FITC-antibody method used in (a), except that the probe was complementary to the insert RNA and the artificial stem-terminator of the transcripts. Fields are shown for the hairpin ribozyme (hp) synthesized from several U6 promoter variants and the tRNA promoter. Expression of the Rev-binding element (RBE)
to nuclei. First, these transcription units are normally in this strategy to including either the first 19 nucleotide U6 RNA stem, or including the first 27 nucleotides, thus also the business of synthesizing high levels of small, stable, tightly structured RNAs. In several instances strategies providing the sequence known to be required for U6-specific 5′ capping. As expected, including the first 19 and have been devised that allow stabilization and transport of the RNA transcripts while deleting protein binding first 27 nucleotides of U6 significantly increased the levels of the RNA transcripts, with the +27 being both capped sites that would restrict their freedom of movement or block exposure of the insert RNAs. We have investigated and increased three-fold over +19. These U6+27 fusions accumulated to roughly the same levels as fusions to parone of these strategies, the human U6 snRNA promoter, for developing nuclear delivery vehicles for small RNAs.
tial tRNA 5′ leaders. In all cases accumulated transcripts tended to be near full-length, suggesting that if the terBecause the human U6 promoter is upstream of the transcription start site, transcripts can be expressed that minal structures were effectively blocking exonuclease attack and that if internal cleavages occurred, the lack all endogenous U6 RNA sequences. We compared resulting RNA did not accumulate. Normalized to endogenous U6 snRNA, assuming 400 000 U6 RNAs per cell. RNA levels were obtained by quantification of Northern blot hybridization to 32 P-oligo probes specific for the insert RNA ribozyme (Rz), TAR, or RBE. Signal was normalized by hybridization signal of an oligo to endogenous U6 snRNA on the same blot of a denaturing polyacrylamide gel and by estimating the transfection efficiency (±10%) by cotransfected ␤-galactosidase gene staining. The degree to which the transcripts were capped was estimated in selected cases by immunoprecipitation with anti-␥-phosphomethyl antibody and detection of RNA in the supernatant and bound fraction by quantitative Northern analysis. Precipitation efficiency was normalized to the efficiency of precipitation of endogenous U6 snRNA.
Two unexpected conclusions regarding the RNA expression were derived from these data. The first is that the exact RNA inserted in the cassettes strongly influences the level of accumulated RNA in the cell, and in ways that are not necessarily predictable in advance. If one of the inserts could have been predicted to be less stable, it might have been the 28 nt antisense insert, which owing to its relative lack of structure might have been more accessible to endonuclease attack. Instead, the hammerhead ribozyme inserts consistently accumulated at 15-to 20-fold lower levels than any of the other inserts, recognition sites for cellular proteins. The other reason is to avoid extra chances, however small, of potential toxicity when there is no compelling reason to have the extra sequence present. staining whether or not the RNAs had 5′ caps. This suggests that if cytoplasmic localization is needed, it might The second unexpected conclusion was that the default pathway for all RNAs expressed from these promoters be necessary to use active cytoplasmic localization signals. seems to be the nucleus. Although the partial RNA fusions were expected to be nuclear because they could
The inability of ribozymes directed against the HIV U5 region to significantly inhibit HIV gene expression was not be recognized as processed tRNAs for transport, it was thought that the U6 transcripts might require a cap unexpected, given the level of expression and the success reported in the past for ribozymes directed at this for nuclear retention. As shown in Figure 4 , all of the U6 promoter transcripts gave primarily punctate nuclear region. 20, 30 This difference might be explained by the dif-ferences in assay systems, although it is possible that GUAGAGGUACGCAAGUACGCGCUCCACAGGCCU-AUCUAUCGGAU; RNAs expressed by these cassettes are simply unable to co-localize with the HIV RNA targets. The same argu-RBE126 = 5′-GGGAACUCGAUGAAGCGAGCUCUUG-GACACAGCCUCAAUGAGGCUGCAGAAACAAGUAments apply for the expression of TAR RNA. In contrast, expression of minimal Rev binding elements, both wild-CUGACUUCGGAUC. type and a variety of artificially selected aptamers, are Plasmid preparations were performed using the Plasfar more effective at inhibiting HIV gene expression in mid Maxi Kit (Qiagen, Hilden, Germany) followed by a the proviral cotransfection. A large number of speculative phenol:chloroform:isoamyl alcohol (24:24:1) extraction hypotheses could be put forward to explain why Rev and ethanol precipitation. Sequences of expression casinhibitors work in this context while Tat inhibitors and settes and the cloned inserts were verified by DNA the anti-RNA RNAs fail. For example, although both Rev sequencing. and Tat have nuclear functions, the punctate locations of the expressed RNAs might make them unavailable to Transfections interact with those targets, but anti-Rev variants are
Transfections of human 293 cells were carried out using specifically co-localized with Rev during some phase of a modified calcium phosphate protocol. The cells were its biosynthesis or transport.
split to 10-20% confluence in 7 ml DMEM (BioWhitaker, Whatever the causes of the differential response to the Walkersville, MD, USA), 10% fetal bovine serum, 2 mm various inserts, it is clear that it will be necessary to test l-glutamine, 100 units/ml penicillin, and 100 g/ml hypothetical RNA therapeutics directly for effects on the streptomycin on 100 mm plates prior to transfection. Five intended targets in the context of different expression micrograms of plasmid were added to 0.5 ml of 244 mm cassettes. It is hoped that once enough effective RNA CaCl 2 , mixed dropwise into 0.5 ml 2 × HBS (270 mm inhibitor/expression cassette combinations can be identNaCl, 1.5 mm Na 2 HPO 4 , 48 mm HEPES, pH 7.0), and ified, they can be delivered simultaneously to overcome placed dropwise evenly on the media, changing media mutational escape by the virus. The small size of both the daily. For the in situ visualizations the cells were plated promoter cassettes and the insert RNAs might make it to Petri dishes containing microscope cover slips that had possible to combine multiple cassettes in one vector.
been acid washed and coated with gelatin (type b: from Nuclear-directed cassettes expressing several types of bovine skin, 2% solution, Sigma, St Louis, MO, USA). RNA inhibitors could be combined with cytoplasmTransfection efficiencies were tested by cotransfecting directed promoter cassettes for other types of RNAs.
pCMV␤ and then assaying the cells for ␤-galactosidase activity.
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Materials and methods
Northern hybridizations RNA samples prepared from transiently transfected Preparation of recombinant clones human 293 cells, were separated on 6% acrylamide gels Construction of the U6+1, U6+19 and tRNA met expression containing 8 m urea along with known RNA size markcassettes was described previously. 36 Each of these casers. 39 The RNA was then blotted to maximum strength settes was cloned into pTZ18U (Bio-Rad, Hercules, CA, Nytran (Schleicher and Schuell, Keene, NH, USA) using USA) that had been restricted with BamHI and HincII.
the Genie electroblotter (Idea Scientific, Minneapolis, The resulting vectors are pTZU6+1, pTZU6+19 and MN, USA) under conditions specified by the manufacpTZtRNA. The U6+27 cassette was constructed by PCR turer. The RNA was UV-cross-linked to the Nytran by amplification from 265 nucleotides upstream of the placing each side on a transilluminator (Fotodyne, Model human U6 gene transcription initiation site through the 3-3000; New Berlin, WI, USA) for 2 min. Oligodeoxynufirst 27 nucleotides of the transcribed gene. 14, 15, 37 This cleotide probes to insert RNA were labeled using polynufragment was substituted for the similar DNA segment cleotide kinase (New England Biolabs, Beverly, MA, of pTZU6+1. The SalI cloning site was provided in the USA) and ␥ 32 P ATP. Separate probes were prepared oligodeoxynucleotide used in the PCR.
against the hairpin ribozyme's catalytic domain, TAR and The small RNAs expressed in the various expression RBE transcripts and endogenous human U6 snRNA. The vectors include two hammerhead ribozymes (HH1 and sequence of each is: 5′TACCAGGTAATATACCA-HH2), a hairpin ribozyme (hp), 20, 30 two small RNA CAACGTGTGTTTCTCTG 3′ (hairpin); 5′ CTAGTCTAGligands for the Tat and Rev proteins (TAR RNA and ACCAGAGAGCTCCCAGGCTCAGATCTGGGTCGAC -RBE), 10, 32, 33, 35 and HIV antisense RNA (AS). The inserts GCGT3′ (TAR); 5′CTAGTCTAGAAGATACAGAGTC-consisted of synthetic oligodeoxynucleotides, corre-CACAAAC GTGTTTCTCAAT GCA CCCGTCGACGCGT sponding to the RNA sequences in Figure 2 plus flanking 3′ (RBE); 5′GCGTGTCATCCTTGCGCAGGGGCC3′ (U6 SalI and XbaI cloning sites. The inserted sequences of the snRNA). RNA blots underwent a 1 h prehybridization at 'TAR' and 'RBE' aptamers are given in Figure 2 (RBE = 60°C in 5 × SSPE buffer, 200 mg/ml salmon testis DNA 'Rev aptamer'). The other Rev aptamers tested for the (Sigma), 1% SDS. Hybridization was performed by data in Figure 5 were obtained by Giver et al. 33 Their adding labeled oligo probes to the prehybridization sequences are:
buffer and continuing incubation overnight. Blots were washed once with 50 ml of wash buffer (2 × SSPE, 1% RBE6 = 5′-GGGAACUCGAUGAAGCGAGCUCUU-GGACACAGCCUCAAUGAGGCUGCAGAUACAAGU-SDS) for 10 min at room temperature, followed by three 100 ml washes, at the hybridization temperature, for 30 ACUGACUUCGGAUC; RBE63 = 5′-GGGAACTCGAUGAAGCGAAUUCUGmin each. The membrane was then exposed to a storage phosphor screen and subsequently scanned on the Mol-GACUCCGUAUGCAAGUACGUUGAGCAACAGGCC-UAUCUAUCGGAU; ecular Dynamics PhosphorImager 445 SI (Sunnyvale, CA, USA). Image analysis, for quantification of hybridization RBE86 = 5′-GGGAACUCGAUGAAGCGAAUUCUGU-signals, was carried out using IP Lab Gel Software (Signal USA) Diaphot inverted microscope adapted for use with the Biorad Confocal Laser Scanning Imaging System Analytic Corporation; Vienna, VA, USA). Expressed RNA copy number was estimated relative to endogenous (model MRC-600). Imaging was done with CoMOS Version 6.03 software (BioRad). Images shown in Figure 4b U6 snRNA in each sample (400 000 copies per cell) 23 normalizing for approximate transfection efficiency measwere obtained using the same settings to allow qualitative comparison of signal strengths. ured by staining parallel cotransfections with pCMV␤.
Immunoprecipitations
HIV-1 antiviral assay The presence of a ␥-phosphomethyl-GTP cap structure on For determination of anti-HIV activity of the RNA aptatranscripts was tested by immunoprecipitation essenmers, transient assays were performed by cotransfection tially as described. 27 RNA (4 g) prepared from transiof the expression plasmid DNA and infectious HIV proently transfected human 293 cells was incubated with 40 viral DNA. 293 Cells were grown for 24 h in six-well g of anti-me pppN cap antibody (provided by Ram polystyrene tissue culture plates in 2 ml EMEM supReddy, Baylor College of Medicine), for 40 min on ice, in plemented with 10% FBS, and transfected according to a NET2 buffer. Pansorbin (100 l) (Calbiochem) was then modified calcium phosphate transfection method of added and allowed to incubate on ice for 40 min with
Wigler et al. 41 The DNA mixture consisted of 4 g candioccasional mixing. The bound portion was then pelleted date or control test plasmid, 0.1 g human growth horby centrifugation, the supernatant was removed and mone (HGH) transfection control pTKGH (Nichols Instisaved. The pellet was then washed twice with NET2 tute Diagnostics, San Juan Capistrano, CA, USA), and 0.1 buffer containing 0.05% NP40, the first of these two g HIV-1 DNA pNL4-3 (NIH AIDS Research and Referwashes was pooled with the supernatant and then SDS ence Reagent Program, Bethesda, MD, USA). After 5 h, was added to a concentration of 0.2%. The pellet containthe DNA precipitate medium was replaced with fresh ing bound RNA was then resuspended in NET2 buffer EMEM-10% FBS and observed for 3 days. Supernatant containing 0.2% SDS. Bound and unbound fractions were fluid was collected and analyzed for reverse transcriptase incubated at 65°C for 10 min and then extracted with (RTase) activity as described. 42 32 P-TTP incorporation equal volumes of phenol and then chloform. The RNA was measured using a phosphoimager (Ambis, San was then ethanol precipitated and analyzed by Northern Diego, CA, USA). Human growth hormone was meashybridizations as above.
ured using an enzyme immunoassay (HGH-GES, Nichols Institute Diagnostics) and did not influence the growth Labeling of in situ probes of HIV-1. RTase results were used only if the transfection Antisense probes were labeled with digoxigenin-11-control showed the presence of HGH. dUTP (Boehringer Mannheim, Indianapolis, IN, USA) by assymetric PCR using Taq DNA polymerase. 40 Synthetic 32 The probe sequences are: 5′GGAACGATAC bodies, and David Spector and Vidya Sarma for helpful AGAGAAGATTAGCATGGCCCCTGCGCAAGGATGA advice. This work was supported by PHS grant AI33263 CACGCAAATTCGTGAAGCG3′ (U6); 5′CCAGAGAAA to DRE, PHS grant AI36083 to AE, PHS grants AI25959 CACACGTTGTGGTATATTACCTGGTACGCCGAATT and AI29329 to JJR, PHS grant AI38592 to JAZ and a CTAGAGCGGACTTCGGTCCGCTTT3′ (hairpin); 5′CCA grant to DRE from the International Foundation for the GATCTGAGCCTGGGAGCTCTCTGGTCTAGAGCGGA Ethical Research. Oligonucleotide synthesis was partially CTTCGGTCCGCTT3′ (TAR); 5′GGGTGCAATGAGAAQ subsidized by grant P30CA46592 to the University of ACACGTTTGTGGACTCTGTATCTTCTAGAGCGGACT Michigan Cancer Center. TCGGTCCGCTT3′ (RBE). Priming oligodeoxynucleotides containing 17, 18, 21 and 21 nt were used that annealed to the 3′ end of these templates. Labeling reac-
